Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174055 · ClinicalTrials.gov registry record
Identifying and Measuring Depression in Older Cancer Patients
A clinical trial of Older Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 329
- Enrollment target
- 1
- Study location
NCT02174055: Active study of Older Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02174055 is a study of Older Cancer Patients that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 329 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02174055, a study of Older Cancer Patients, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 329 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop an accurate and useful way of measuring older patients' moods and reactions to the combined issue of cancer treatment and aging. Also, the purpose of this study is to test a new self-report measure of depressive symptoms tailored to the needs of older adults with cancer. Findings from this research will help us develop improved methods of diagnosis and treatment.
Primary Outcome
This protocol aims to design, develop and pilot test a psychometric assessment for depression in older cancer patients.
Conditions Studied
Interventions
- BEHAVIORAL Patient Interviews
- BEHAVIORAL newly developed questionnaire
- BEHAVIORAL Pilot Testing the Draft Measure
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2014-06-20 |
| Est. Completion | 2026-06 |
What the registry record for NCT02174055 still lists
NCT02174055 is an observational study that tracks outcomes without assigning an intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Older Cancer Patients appearing as the primary indexed condition, and to 3 interventions - of which Patient Interviews is the first listed.
NCT02174055 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02174055 about?
NCT02174055 is a clinical study titled "Identifying and Measuring Depression in Older Cancer Patients". The purpose of this study is to develop an accurate and useful way of measuring older patients' moods and reactions to the combined issue of cancer treatment and aging. Also, the purpose of this study is to test a new self-report measure of depressive symptoms tailored to the needs of older adults w...
What is the current status of trial NCT02174055?
This trial is currently active not recruiting. The enrollment target is 329 participants. The study started on 2014-06-20. Estimated completion is 2026-06.
What conditions does trial NCT02174055 study?
This clinical trial studies the following conditions: Older Cancer Patients.
What interventions are being tested in trial NCT02174055?
The interventions under investigation include: Patient Interviews (BEHAVIORAL), newly developed questionnaire (BEHAVIORAL), Pilot Testing the Draft Measure (BEHAVIORAL).
Who is sponsoring clinical trial NCT02174055?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02174055 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06036446 · 329 participants · NA
LATe Cerclage in High-risk Pregnancies (LATCH)
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI